-
Nov 18, 2026, 7:30 am67 ptsChina approved a drug for some patients with advanced lung cancer in May 2024. American doctors still can't routinely offer it. On November 15, Summit Therapeutics announced that the Food and Drug Administration (FDA) had rejected its application to market the drug ivonescimab for patients whose…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.




